Cyanidin-3-Glucoside (C3G).

In water-based formulas ascorbic acid and anthocyanins degrade each other through a condensation and co-oxidation route, so both the colour and the intact glycoside fall faster together than apart. This is long-standing beverage chemistry and is why the pair needs low oxygen and low pH handling.

Cyanidin-3-glucoside exists as the red flavylium cation only at low pH and loses structure as pH rises toward neutral. Citric acid holds the acidic pH that keeps the intact glycoside present, and it also binds trace metals that would otherwise catalyse its breakdown.

Flavonol glycosides such as rutin stack face to face with the flavylium ring of cyanidin-3-glucoside, shielding it from water attack. This copigmentation is standard practice for holding anthocyanin colour and structure in a finished formula.

Chlorogenic acid forms a stacked complex with the anthocyanin chromophore and slows hydration of the flavylium ring. Fruit matrices that carry both naturally show this stabilising effect.

Quercetin copigments with cyanidin-3-glucoside in solution and, once absorbed, competes for the same intestinal and hepatic glucuronidation and sulfation enzymes. The result is physical stabilisation in the bottle and shared phase II handling in the body.

The catechol arrangement on the cyanidin B ring binds ferrous and ferric iron into an insoluble complex in the gut lumen. Taken in the same dose window this lowers how much non-heme iron is taken up, so spacing them apart is the usual practice.

Only a small fraction of an ingested anthocyanin glycoside is absorbed intact; most reaches the colon where bacterial beta-glucosidases cleave the sugar and the released aglycone breaks down further to phenolic acids such as protocatechuic acid. Lactobacillus species carry that glucosidase activity. The pairing changes which metabolites appear, and those metabolites are what circulate at meaningful concentrations.

Fermentable fibre feeds the Bifidobacterium and Lactobacillus populations that carry out anthocyanin deglycosylation and ring fission. Shifting that community shifts the phenolic metabolite profile downstream of a cyanidin dose. The link is mechanistic and measured as metabolites, not as a clinical result.

Cyanidin-3-glucoside is a water-phase radical scavenger while tocopherols sit in the lipid membrane, so the two cover different compartments of the same oxidative process. Polyphenols can regenerate the tocopheroxyl radical back to tocopherol in model systems. This describes redox chemistry and markers, not a health outcome.

Anthocyanin quinone products are conjugated by glutathione S-transferases, and anthocyanins in turn upregulate Nrf2-driven glutathione synthesis enzymes in cell work. The two therefore sit on the same intracellular antioxidant axis. Everything here is measured as enzyme expression or marker levels in laboratory systems.

The ortho-dihydroxy B-ring of cyanidin binds transition metals, forming coloured complexes that shift both the pigment's stability and the metal's redox behaviour. In a formula this can alter the colour of the product and reduce the free ion pool. Separate a chelating polyphenol from a mineral dose if free-ion delivery is the point.

Milk proteins bind anthocyanins through hydrogen bonding and hydrophobic contact, which is why anthocyanin colour and measured free-polyphenol content drop when berry material is put into a dairy base. The bound fraction is not lost from the product but it is less available to the assay and, in feeding work, to early absorption. This is a matrix effect worth designing around.

Cyanidin-3-glucoside exists as the red flavylium cation only at low pH; as pH rises it converts through the colourless carbinol pseudobase to quinoidal and chalcone forms. Alkalising a formula therefore changes both its colour and the chemical species present. Acidified liquids keep the pigment in its stable cationic form.

Both are substrates for UGT and SULT conjugation in the enterocyte and for efflux back into the gut lumen, so a large dose of one can occupy the same conjugating and transport capacity. Co-dosing shifts the balance between parent compound and conjugate in plasma. That is a pharmacokinetic observation, not a statement that either works better.

Both compounds engage the same stress-response transcriptional programme in cell work, and pterostilbene's methylated structure gives it a different absorption and metabolism profile from an anthocyanin glycoside. Pairing them covers the pathway from two pharmacokinetic directions. The grounding is cell and animal work, so read it as mechanistic.

Riboflavin is a photosensitiser that generates singlet oxygen and radicals under light, and anthocyanins degrade rapidly under exactly those conditions. A clear bottle containing both loses pigment faster than one containing either. This is formulation stability rather than anything happening in a person.